Search Results - "Fitter, Stephen"

Refine Results
  1. 1

    The Mesenchymal Precursor Cell Marker Antibody STRO‐1 Binds to Cell Surface Heat Shock Cognate 70 by Fitter, Stephen, Gronthos, Stan, Ooi, Soo Siang, Zannettino, Andrew C.W.

    Published in Stem cells (Dayton, Ohio) (01-04-2017)
    “…Since its discovery more than 25 years ago, the STRO‐1 antibody has played a fundamental role in defining the hierarchical nature of mesenchymal precursor…”
    Get full text
    Journal Article
  2. 2

    mTORC1 Plays an Important Role in Skeletal Development by Controlling Preosteoblast Differentiation by Fitter, Stephen, Matthews, Mary P., Martin, Sally K., Xie, Jianling, Ooi, Soo Siang, Walkley, Carl R., Codrington, John D., Ruegg, Markus A., Hall, Michael N., Proud, Christopher G., Gronthos, Stan, Zannettino, Andrew C. W.

    Published in Molecular and cellular biology (01-04-2017)
    “…The mammalian target of rapamycin complex 1 (mTORC1) is activated by extracellular factors that control bone accrual. However, the direct role of this complex…”
    Get full text
    Journal Article
  3. 3

    Osteocalcin‐dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance by Tangseefa, Pawanrat, Martin, Sally K., Fitter, Stephen, Baldock, Paul A., Proud, Christopher G., Zannettino, Andrew C. W.

    Published in Journal of cellular physiology (01-05-2018)
    “…The skeleton has recently emerged as a critical insulin target tissue that regulates whole body glucose metabolism and male reproductive function. While our…”
    Get full text
    Journal Article
  4. 4

    Calorie restriction has no effect on bone marrow tumour burden in a VkMYC transplant model of multiple myeloma by Bradey, Alanah L., Fitter, Stephen, Duggan, Jvaughn, Wilczek, Vicki, Williams, Connor M. D., Cheney, Emma AJ, Noll, Jacqueline E., Tangseefa, Pawanrat, Panagopoulos, Vasilios, Zannettino, Andrew C. W.

    Published in Scientific reports (30-07-2022)
    “…Multiple myeloma (MM) is an incurable haematological malignancy, caused by the uncontrolled proliferation of plasma cells within the bone marrow (BM). Obesity…”
    Get full text
    Journal Article
  5. 5

    Dysregulation of bone remodeling by imatinib mesylate by Vandyke, Kate, Fitter, Stephen, Dewar, Andrea L., Hughes, Timothy P., Zannettino, Andrew C.W.

    Published in Blood (28-01-2010)
    “…Imatinib mesylate is a rationally designed tyrosine kinase inhibitor that has revolutionized the treatment of chronic myeloid leukemia and gastrointestinal…”
    Get full text
    Journal Article
  6. 6

    Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion by Fitter, Stephen, Vandyke, Kate, Gronthos, Stan, Zannettino, Andrew C W

    Published in Journal of molecular endocrinology (01-06-2012)
    “…Improved glucose and lipid metabolism is a unique side effect of imatinib therapy in some chronic myeloid leukaemia (CML) patients. We recently reported that…”
    Get full text
    Journal Article
  7. 7

    Long-term imatinib therapy promotes bone formation in CML patients by Fitter, Stephen, Dewar, Andrea L., Kostakis, Panagiota, To, L. Bik, Hughes, Timothy P., Roberts, Marion M., Lynch, Kevin, Vernon-Roberts, Barrie, Zannettino, Andrew C.W.

    Published in Blood (01-03-2008)
    “…Imatinib inhibits tyrosine kinases important in osteoclast (c-Fms) and osteoblast (platelet-derived growth factor receptor [PDGF-R], c-Abl) function,…”
    Get full text
    Journal Article
  8. 8

    The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo by Vandyke, Kate, Dewar, Andrea L, Diamond, Peter, Fitter, Stephen, Schultz, Christopher G, Sims, Natalie A, Zannettino, Andrew CW

    Published in Journal of bone and mineral research (01-08-2010)
    “…Dasatinib is a potent tyrosine kinase inhibitor that is used to treat chronic myeloid leukemia in patients resistant or intolerant to imatinib mesylate. While…”
    Get full text
    Journal Article
  9. 9
  10. 10

    NVP‐BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells by Martin, Sally K, Fitter, Stephen, Bong, Li Fei, Drew, Jennifer J, Gronthos, Stan, Shepherd, Peter R, Zannettino, Andrew CW

    Published in Journal of bone and mineral research (01-10-2010)
    “…Osteoblasts are bone‐forming cells derived from mesenchymal stromal cells (MSCs) that reside within the bone marrow. In response to a variety of factors, MSCs…”
    Get full text
    Journal Article
  11. 11

    A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells by Gronthos, Stan, Fitter, Stephen, Diamond, Peter, Simmons, Paul J, Itescu, Silviu, Zannettino, Andrew C W

    Published in Stem cells and development (01-12-2007)
    “…Numerous studies support the concept that the nonhemopoietic cells of the bone marrow (BM), are derived from a population of multipotent bone marrow stromal…”
    Get more information
    Journal Article
  12. 12

    Characterization of Mice Lacking the Tetraspanin Superfamily Member CD151 by Wright, Mark D., Geary, Sean M., Fitter, Stephen, Moseley, Gregory W., Lau, Lai-Man, Sheng, Kuo-Ching, Apostolopoulos, Vasso, Stanley, Edouard G., Jackson, Denise E., Ashman, Leonie K.

    Published in Molecular and Cellular Biology (01-07-2004)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  13. 13

    The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin by Tangseefa, Pawanrat, Martin, Sally K, Chin, Peck Yin, Breen, James, Mah, Chui Yan, Baldock, Paul A, Wittert, Gary A, Page, Amanda J, Proud, Christopher G, Fitter, Stephen, Zannettino, Andrew C W

    Published in Bone Research (08-02-2021)
    “…Overnutrition causes hyperactivation of mTORC1-dependent negative feedback loops leading to the downregulation of insulin signaling and development of insulin…”
    Get full text
    Journal Article
  14. 14

    Characterization of the role of Samsn1 loss in multiple myeloma development by Friend, Natasha L., Hewett, Duncan R., Panagopoulos, Vasilios, Noll, Jacqueline E., Vandyke, Kate, Mrozik, Krzysztof M., Fitter, Stephen, Zannettino, Andrew C.W.

    Published in FASEB bioAdvances (01-09-2020)
    “…The protein SAMSN1 was recently identified as a putative tumor suppressor in multiple myeloma, with re‐expression of Samsn1 in the 5TGM1/KaLwRij murine model…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Deconvolution of a Complex Target Using DNA Aptamers by Fitter, Stephen, James, Robert

    Published in The Journal of biological chemistry (07-10-2005)
    “…In vitro selection of single-stranded nucleic acid aptamers from large random sequence libraries is now a straightforward process particularly when screening…”
    Get full text
    Journal Article
  17. 17

    Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival by Thomas, Daniel, Powell, Jason A, Green, Benjamin D, Barry, Emma F, Ma, Yuefang, Woodcock, Joanna, Fitter, Stephen, Zannettino, Andrew C W, Pitson, Stuart M, Hughes, Timothy P, Lopez, Angel F, Shepherd, Peter R, Wei, Andrew H, Ekert, Paul G, Guthridge, Mark A

    Published in PLoS biology (01-03-2013)
    “…The dual specificity protein/lipid kinase, phosphoinositide 3-kinase (PI3K), promotes growth factor-mediated cell survival and is frequently deregulated in…”
    Get full text
    Journal Article
  18. 18

    Molecular and cellular mechanisms of chemoresistance in paediatric pre–B cell acute lymphoblastic leukaemia by Lill, Caleb B., Fitter, Stephen, Zannettino, Andrew C. W., Vandyke, Kate, Noll, Jacqueline E.

    Published in Cancer and metastasis reviews (01-12-2024)
    “…Paediatric patients with relapsed B cell acute lymphoblastic leukaemia (B-ALL) have poor prognosis, as relapse-causing clones are often refractory to common…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Brief Report: The Differential Roles of mTORC1 and mTORC2 in Mesenchymal Stem Cell Differentiation by Martin, Sally K., Fitter, Stephen, Dutta, Ankit K., Matthews, Mary P., Walkley, Carl R., Hall, Michael N., Ruegg, Markus A., Gronthos, Stan, Zannettino, Andrew C. W.

    Published in Stem cells (Dayton, Ohio) (01-04-2015)
    “…Adipocytes (AdCs) and osteoblasts (OBs) are derived from mesenchymal stem cells (MSCs) and differentiation toward either lineage is both mutually exclusive and…”
    Get full text
    Journal Article